Gold Nanostars: A Novel Platform for Developing
211At
GNS
TAT
astatine-211
cancer therapy
gold nanostars
targeted alpha-particle therapy
Journal
International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847
Informations de publication
Date de publication:
2021
2021
Historique:
received:
02
07
2021
accepted:
28
08
2021
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
25
11
2021
Statut:
epublish
Résumé
To develop an innovative Star-shaped gold nanoparticles, gold nanostars (GNS), were used as the platform for The efficiency of labeling GNS with The new
Identifiants
pubmed: 34737567
doi: 10.2147/IJN.S327577
pii: 327577
pmc: PMC8560129
doi:
Substances chimiques
Gold
7440-57-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7297-7305Informations de copyright
© 2021 Liu et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Brain. 2007 Oct;130(Pt 10):2596-606
pubmed: 17785346
Nucl Med Biol. 2020 Nov - Dec;90-91:15-22
pubmed: 32916470
J Nucl Med. 2018 Jun;59(6):878-884
pubmed: 29545378
Small. 2007 Sep;3(9):1496-9
pubmed: 17668431
J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
pubmed: 21228314
Nucl Med Biol. 1997 Apr;24(3):255-61
pubmed: 9228660
Int J Nanomedicine. 2019 May 09;14:3403-3411
pubmed: 31190799
Adv Enzyme Regul. 2001;41:189-207
pubmed: 11384745
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Nanomaterials (Basel). 2019 Apr 18;9(4):
pubmed: 31003512
J Labelled Comp Radiopharm. 2018 Mar;61(3):154-164
pubmed: 29080397
Drug Target Insights. 2007;2:197-207
pubmed: 21901074
Blood. 2013 May 2;121(18):3759-67
pubmed: 23471305
Immunotherapy. 2019 Oct;11(15):1293-1302
pubmed: 31530200
Nucl Med Biol. 2021 Sep-Oct;100-101:12-23
pubmed: 34144505
Theranostics. 2015 May 23;5(9):946-60
pubmed: 26155311
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
Sci Rep. 2017 May 31;7(1):2579
pubmed: 28566709
J Nucl Med. 2018 Jul;59(7):1020-1027
pubmed: 29496984
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):999-1010
pubmed: 29350258
Bioconjug Chem. 2010 May 19;21(5):797-802
pubmed: 20397686
Mol Pharm. 2019 Aug 5;16(8):3524-3533
pubmed: 31268724
Nanotechnology. 2012 Feb 24;23(7):075102
pubmed: 22260928
Mol Cancer Ther. 2019 Jul;18(7):1195-1204
pubmed: 31072830
Sci Rep. 2017 Aug 17;7(1):8606
pubmed: 28819209
Curr Pharm Des. 2000 Sep;6(14):1433-55
pubmed: 10903402
J Nucl Med. 2005 Dec;46(12):2061-7
pubmed: 16330571
J Nucl Med. 2008 Jan;49(1):30-8
pubmed: 18077533
Nanotechnology. 2019 Jul 5;30(27):275101
pubmed: 30856613
Clin J Oncol Nurs. 2016 Oct 1;20(5 Suppl):S2-8
pubmed: 27668386
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18590-18596
pubmed: 31451630
Nucl Med Biol. 2018 Jan;56:10-20
pubmed: 29031230